In 2015, introduction of a disease staging system offered a framework for benchmarking progression to clinical type 1 ...

Synthetic data, generated through artificial intelligence technologies such as generative adversarial networks and latent ...

The COVID-19 pandemic reminded us of what vaccines can do to prevent life-threatening diseases.1 Respiratory infections such ...

The 2021 approval by regulatory agencies of belimumab, a B lymphocyte stimulator (BLyS) inhibitor, and the 2022 approval of anifrolumab, a type I interferon inhibitor, has increased the therapeutic ...